Pharmadrug Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.01	0.08	0.41	0.01	0.96	2.13
Short-Term Investments	-	-	0.01	0.32	0.34	2.27
Cash & Short-Term Investments	0.01	0.08	0.42	0.33	1.3	4.4
Cash Growth	-94.94%	-82.26%	28.49%	-74.58%	-70.59%	757.33%
Accounts Receivable	-	-	-	-	0.02	0.04
Other Receivables	0.02	0.02	0.02	0.02	0.06	0.15
Receivables	0.02	0.02	0.02	1	0.08	0.18
Inventory	-	-	-	-	0.16	0.04
Prepaid Expenses	-	0.01	0.01	0.01	0.01	0.03
Restricted Cash	0.01	0.04	0.15	-	-	-
Other Current Assets	-	-	-	-	0.05	0.03
Total Current Assets	0.03	0.15	0.6	1.34	1.59	4.69
Property, Plant & Equipment	-	-	-	-	0.1	0.12
Goodwill	-	-	-	6.24	10.47	4.59
Other Intangible Assets	0.53	0.56	0.6	4.53	7.35	4.29
Total Assets	0.56	0.71	1.2	12.11	19.52	13.69
Accounts Payable	0.51	0.37	0.45	0.53	0.25	0.35
Accrued Expenses	0.07	0.24	0.45	0.25	0.19	0.21
Current Portion of Long-Term Debt	1.49	1.35	1.77	1.42	-	-
Current Portion of Leases	-	-	-	-	0.04	0.06
Total Current Liabilities	2.07	1.96	2.66	2.2	0.48	0.62
Long-Term Debt	-	-	-	-	0.79	1.03
Long-Term Leases	-	-	-	-	0.04	0.04
Long-Term Deferred Tax Liabilities	-	-	-	1.01	1.25	1
Other Long-Term Liabilities	-	-	-	0.07	0.1	0.09
Total Liabilities	2.07	1.96	2.66	3.28	2.66	2.78
Common Stock	34.01	33.99	33.21	31.22	30.61	21.83
Retained Earnings	-39.36	-39.11	-38.3	-25.12	-19.4	-15.86
Comprehensive Income & Other	3.71	3.71	3.38	2.74	5.66	3.68
Total Common Equity	-1.63	-1.4	-1.7	8.84	16.87	9.66
Minority Interest	0.12	0.16	0.24	-	-	1.26
Shareholders' Equity	-1.51	-1.24	-1.47	8.84	16.87	10.91
Total Liabilities & Equity	0.56	0.71	1.2	12.11	19.52	13.69
Total Debt	1.49	1.35	1.77	1.42	0.87	1.13
Net Cash (Debt)	-1.48	-1.27	-1.34	-1.09	0.43	3.28
Net Cash Growth	-	-	-	-	-86.91%	-
Net Cash Per Share	-0.01	-0.01	-0.02	-0.02	0.01	0.16
Filing Date Shares Outstanding	108.23	108.2	104.69	50.8	49.48	48.62
Total Common Shares Outstanding	108.23	107.73	88.17	50.8	48.69	34.52
Working Capital	-2.04	-1.81	-2.07	-0.86	1.11	4.07
Book Value Per Share	-0.02	-0.01	-0.02	0.17	0.35	0.28
Tangible Book Value	-2.16	-1.97	-2.31	-1.94	-0.96	0.78
Tangible Book Value Per Share	-0.02	-0.02	-0.03	-0.04	-0.02	0.02
Machinery	-	-	-	-	0.05	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.